Gilead Sciences said on Monday its experimental HIV treatment was found to be statistically non-inferior to its top-selling ...
TipRanks on MSN
GSK’s new study on belantamab mafodotin: A potential game-changer for multiple myeloma treatment
GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) has announced a new clinical study titled ‘A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback